Parker Waichman LLP

Lamictal Lawsuit | Side Effects : Birth Defects, Cleft Lip, Cleft Palate

  Lamictal Birth Defects Reported to the FDA. In September 2011, AdverseEvents, Inc. reported that its analysis of the FDA’s Adverse Event Reporting System (AERS) indicated that Lamictal was more dangerous to unborn babies than previously thought. The analysis indicated that moving Lamictal from its current FDA pregnancy risk class, Category C (“no known human […]

Lamictal Side Effects

 

Lamictal Birth Defects Reported to the FDA. In September 2011, AdverseEvents, Inc. reported that its analysis of the FDA’s Adverse Event Reporting System (AERS) indicated that Lamictal was more dangerous to unborn babies than previously thought. The analysis indicated that moving Lamictal from its current FDA pregnancy risk class, Category C (“no known human risk”), to Category D (“positive evidence of human fetal risk”) could be warranted.

In conducting its analysis, AdverseEvents used a proprietary process called RxFilter to analyze the FDA’s AERS database for Lamictal birth defects, stillbirths and congenital abnormalities potentially associated with 18 anti-epilepsy medications, including Lamictal, that are commonly prescribed during pregnancy. The time period covered by the AdverseEvents analysis was January 1, 2004 to March 31, 2011.

Lamictal Birth Defects Reported : Babies exposed to Lamictal during the first three months of pregnancy might have a higher chance of being born with a cleft lip or cleft palate

According to AdverseEvents, an average birth defect rate comparison between Lamictal and top Category D drugs yielded a surprising result; no meaningful differences were found. “These results indicate that regulatory bodies may want to consider category shifts for some of the most widely used antiepilepsy medications. Prospective studies, however, are needed to establish the exact incidence of these adverse events and to determine appropriate changes in category labeling, if any. This analysis warrants the attention of all healthcare providers and patients associated with epilepsy medications,” a statement from AdverseEvents said.

On September 29, 2006, the FDA notified healthcare professionals and patients of new information from the North American Antiepileptic Drug Pregnancy Registry signifying that babies exposed to ‘Lamictal’, designated to treat seizures and bipolar disorder, during the first three months of pregnancy might have a higher chance of being born with a cleft lip or cleft palate. Women who are pregnant and are taking ‘Lamictal’ or who are thinking about taking this medication are strongly urged to not start or stop taking the medication without first talking to their physician. More research is needed to be sure about the possibility of the increased chance of cleft lip or cleft palate developing in babies of pregnant women who take ‘Lamictal’.

On August 8, 2006 drug manufacturer GlaxoSmithKline warned pregnant women of the potential association between the drug Lamictal (generic: lamotrigine) and cleft palate or cleft lip in newborns. Lamictal gained FDA (Food & Drug Association) approval in 1994 and was approved by Health Canada in 1995. Lamictal is prescribed to combat epilepsy.

GlaxoSmithKline in conjunction with Health Canada stated that new statistics from a pregnancy registry recommend a correlation between taking ‘Lamictal’ during the first trimester of pregnancy, and increased risk of cleft lip and/or palate in the baby. Based upon data from the public oral clefts is one of the most ordinary major birth defects, occurring at rates of 0.5 to 2.16 per 1,000 births. Data from the pregnancy registry illustrated three cases of cleft palate and two cases of cleft lip in infants born to 564 users ‘Lamictal’, a rate of 8.9 per 1,000.

Current patients taking Lamictal have been instructed to alert their doctors if they become pregnant or intend to become pregnant. Immediate stoppage of anti-eplieptic therapy may lead to breakthrough seizures with can cause serious risks for both the mother and the fetus and should be avoided. Peter Schram, a spokesman for GlaxoSmithKline, said other discontinuation symptoms could include rashes, dizziness, headaches, nausea and blurred vision.

Need Legal Help Regarding Lamictal?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations regarding Lamictal lawsuits. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
" Great Job!"A very professional Law Firm . The Service was great keeping me well informed step by step during the process .Parker watchman handled my case wonderfully. I was very happy and satisfied with my settlement. I recommend them to any one.
Marwa Amin
6 years ago
5 Star Reviews 150
I was extremely pleased with my service! Michele Josama was an absolute gem. She was so kind and professional. She handled my family member’s case and worked diligently on our behalf. We are truly grateful for her hard work!! Thank you so much!!!
Naomi Paul
5 years ago
5 Star Reviews 150
Great people great experience 5star
Renee Stumpf
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038